SECsense Logo

USANA Health Sciences 8-K Report: Key Updates from December 23, 2024

$USNA
Form 8-K
Filed on: 2024-12-23
Source
USANA Health Sciences 8-K Report: Key Updates from December 23, 2024

Based on the provided section of the financial report, here are the key pieces of information and insights:

  1. Entity Information:
  • Company Name: USANA Health Sciences, Inc.
  • CIK Number: 0000896264
  • SEC File Number: 001-35024
  • Tax ID: 87-0500306
  • Address: 3838 West Parkway Boulevard, Salt Lake City, UT 84120
  • Telephone: 801-954-7100
  1. Filing Details:
  • Type of Filing: 8-K (Current Report)
  • Filing Date: December 23, 2024
  1. Securities Information:
  • Security Type: Common Stock
  • Par Value: $0.001 per share
  • Ticker Symbol: USNA
  • Exchange: NYSE (New York Stock Exchange)
  1. Reporting Context:
  • The report indicates a single date for the reporting period, which is December 23, 2024, suggesting that the filing may pertain to a specific event or occurrence on that date.

Insights:

  • The 8-K filing indicates that USANA Health Sciences, Inc. may have disclosed significant events or changes that investors should be aware of as of December 23, 2024.
  • The presence of a filing type (8-K) typically suggests that the company is reporting on important events such as mergers, acquisitions, changes in executive leadership, or other material events that could impact shareholder value.
  • The information on the common stock suggests that the company is publicly traded, which means it is subject to regulatory scrutiny and must adhere to reporting requirements set forth by the SEC.

Overall, this report marks a critical point in time for USANA Health Sciences, Inc., and stakeholders should review the complete 8-K filing for detailed disclosures related to the reported date.